Connect with us

Covid-19 Updates

COVID-19 study: Natural immunity vs Vaccine-induced immunity Compared

Published

on

Ivermectin For COVID-19

COVID-19 study: Natural immunity vs Vaccine-induced immunity Compared. The study was conducted by Sivan Gazit, Roei Shlezinger, Galit Perez, Roni Lotan, Asaf Peretz, Amir Ben-Tov, Dani Cohen, Khitam Muhsen, Gabriel Chodick, Tal Patalon.

A study “comparing SARS-CoV-2 natural immunity to vaccine-induced immunity: reinfections versus breakthrough infections” has concluded that natural immunity confers longer-lasting and stronger protection against infection, symptomatic disease and hospitalization caused by the Delta variant of SARS-CoV-2, compared to the BNT162b2 two-dose vaccine-induced immunity.

They warned that their article is a preprint and has not been peer-reviewed which means it reports new medical research that has yet to be evaluated and so should not be used to guide clinical practice.

Reads part of the article:
Abstract
Background Reports of waning vaccine-induced immunity against COVID-19 have begun to surface. With that, the comparable long-term protection conferred by previous infection with SARS-CoV-2 remains unclear. Methods We conducted a retrospective observational study comparing three groups: (1)SARS-CoV-2-naïve individuals who received a two-dose regimen of the BioNTech/Pfizer mRNA BNT162b2 vaccine, (2) previously infected individuals who have not been vaccinated, and (3) previously infected and single-dose vaccinated individuals. Three multivariate logistic regression models were applied. In all models we evaluated four outcomes: SARS-CoV-2 infection, symptomatic disease, COVID-19-related hospitalization and death. The follow-up period of June 1 to August 14, 2021, when the Delta variant was dominant in Israel.

Results SARS-CoV-2-naïve vaccinees had a 13.06-fold (95% CI, 8.08 to 21.11) increased risk for breakthrough infection with the Delta variant compared to those previously infected, when the first event (infection or vaccination) occurred during January and February of 2021. The increased risk was significant (P<0.001) for symptomatic disease as well.

When allowing the infection to occur at any time before vaccination (from March 2020 to February 2021), evidence of waning natural immunity was demonstrated, though SARS-CoV-2 naïve vaccinees had a 5.96-fold (95% CI, 4.85 to 7.33) increased risk for breakthrough infection and a 7.13-fold (95% CI, 5.51 to 9.21) increased risk for symptomatic disease. SARS-CoV-2-naïve vaccinees were also at a greater risk for COVID-19-related-hospitalizations compared to those that were previously infected.

Conclusions This study demonstrated that natural immunity confers longer-lasting and stronger protection against infection, symptomatic disease and hospitalization caused by the Delta variant of SARS-CoV-2, compared to the BNT162b2 two-dose vaccine-induced immunity. Individuals who were both previously infected with SARS-CoV-2 and given a single dose of the vaccine gained additional protection against the Delta variant.

Competing Interest Statement
The authors have declared no competing interest.

Funding Statement
There was no external funding for the project.

Source – Pindula News

In other news – Passion Java speaks after death hoax: Video

Passion Java speaks after death hoax: Video. The controversial self-proclaimed man of God has spoken out after we woke up to the news that he had passed away. However, the preacher posted a video showing that he is still alive and is currently enjoying himself in Zimbabwe.

Passion Java

Yes, he is in Zimbabwe with his wife and son. They are actually on a family vacation in Victoria Falls. He posted a…Learn More.

news@mbaretimes.com

Entertainment

Trending

Copyright © 2021 - news@mbaretimes.com